|
|
|
|
|
SCIENTIFIC PROGRAM
(click here for a printable version) |
|
|
|
| JULY
9, 2008 |
|
|
| 12:00-15:00 |
|
Afternoon
arrivals, check in at Adams Mark Hotel |
|
|
|
| 15:00-17:00 |
|
Sponsored Symposium
at Adams Mark Hotel |
|
|
MRSA Active
Cephalosporins
Chair person: Alan Tice
and Joseph Paladino |
| 15:00-15:30 |
|
Resistance in Failure
of Community Antibiotics - C. Rotstein (CA) |
| 15:30-16:00 |
|
Clinical Aspects of
Treating MRSA in the Community - Alan Tice (US) |
| 16:00-16:30 |
|
Economic Aspects of
MRSA in the Community - J.Paladino (US)
|
| 16:30-17:00 |
|
Clinical Studies of
Ceftaroline - D. Thye (US) |
|
|
|
| 17:30-22:00 |
|
Buffet
Welcome Reception
at Adams Mark Hotel
|
|
|
|
| JULY
10, 2008 |
|
|
| 8:00-16:00 |
|
Plenary
Sessions at Albright Knox Art Gallery |
|
|
|
|
|
Mechanisms
of Resistance and Response
Chair
persons:
B.Murray and C. Rotstein
|
|
8:00:8:30 |
|
Impact of Vaccines on
Multi Drug Resistant S pneumoniae - KP Klugman (US)
|
|
8:30:9:00 |
|
S.
pneumoniae in CAP: The case against placebos - T. Murphy (US) |
|
9:00-9:30 |
|
Small Colony Variants - Another strategy to resist TX - C. von Eiff (GER) |
|
9:30-10:00 |
|
Intestinal Flora and the
Genomic Impacts of Antibiotics - S. Gill (US) |
|
|
|
|
10:00-11:00 |
|
Coffee Break,
Exhibits, Posters |
|
|
|
|
|
Epidemiology and
Treatment Strategies
Chair persons:
B .Moellering and VL Yu |
| 11:00-11:20 |
|
Foreign Bodies, Biofilms, and Catheter Sepsis
- R. Darouiche (US) |
| 11:20-11:40 |
|
Enterococci - New
Developments in Resistance - B. Murray (US) |
| 11:40-12:00 |
|
CA-MRSA Canadian Aspects
- M. Mulvey (CA) |
| 12:00-12:20 |
|
The Role of Linezolid in RGP
Infections - B. Moellering (US) |
|
|
|
| 12:20-13:30 |
|
Lunch,
Exhibits, Posters |
|
|
|
|
|
|
Virulence Factors
in Gram-positives
Chair
persons:
Y.
Carmeli and H. Lode
|
| 13:30-13:50 |
|
Phage Lytic Enzymes to
Control Gram Positive Bacteria - V. Fischetti (US)
|
|
13:50-14:10 |
|
S. epidermidis
- Not Such An Innocent Pathogen - J. John (US) |
| 14;10-14:30 |
|
S. aureus
- An Evolving Clinical Pathogen in Wounds - P. Dellinger (US)
|
| 14:30-14:50 |
|
C. difficile in the
Hospital, Nursing Home and the Community - R.Bax (UK)
|
|
|
|
| 14:50-16:00 |
|
Coffee
break, Exhibits, Posters |
|
|
|
| 16:00-18:00 |
|
Sponsored Symposium |
|
|
MRSA:
Clinical Trials and other Considerations for Selecting Therapy
Chair
Person: Alan Tice and Ethan Rubenstein
|
| 16:00-16:20 |
|
Cost Analysis and the burden
of MRSA and VREF - Y. Carmeli (IL) |
|
16:20-16:40 |
|
PK/PD of
Anti-Gram-positive Agents vs MRSA - Jerome Schentag (US) |
| 16:40-17:10 |
|
MRSA
Trials - Should they be Targeting Superiority? - Ethan Rubenstein (IS) |
| 17:10-17:40 |
|
MRSA pneumonia: Evidence and
Guidelines - M Niederman (US) |
| 17:40-18:00 |
|
Panel Discussion |
|
|
|
|
18:00-19:30 |
|
Symposium Reception and Dinner at Albright Knox Art Gallery with Tour |
|
|
|
|
JULY 11, 2008 |
|
|
|
|
|
|
8:00-9:00 |
|
Specialty
Clinical Problems in Hospitals |
|
|
Chair
persons: J Mylotte and R. Owens
|
| 8:00-8:30 |
|
Staphylcoccal
Bacteremia: Trials and Tribulations - H. Boucher (US) |
| 8:30-9:00 |
|
C. difficile:
Antibiotic Resistance and Treatment Options -
R. Owens (US) |
|
|
|
| 9:00-9:30 |
|
Break, Exhibits,
Posters
|
|
|
|
|
|
Clinical Aspects
of Resistant Gram Positives
Chair
persons:
A. Tice and E.
Rubinstein
|
| 9:30-10:00 |
|
The
Future in Therapeutics - E.
Rubenstein (CA) |
|
10:00-10:20 |
|
CAP and Multi-Resistant
S. pneumoniae
- T. File (US) |
|
10:20-10:40 |
|
Respiratory Tract Infections in ICUs
- H. Lode (GE) |
|
10:40:11:00 |
|
Severe CAP Risk Factors and
Treatment Strategies - VL. Yu (US) |
| 11:00-11:20 |
|
Panel Discussion: Treatment
of Severe Gram Positive Infections |
|
|
|
|
|
|
PK/PD of
New Anti-gram-postive agents
Chair Persons:
P. Tulkens and A. Lesse
|
| 11:20-11:50 |
|
Modes of Action and
PK/PD of Novel Anti-gram Positive Agents
- PM Tulkens (BE)
|
| 11:50-12:10 |
|
Strategies for MRSA -
What do the animal models tell us? - WA Craig (US)
|
|
12:10-12:30 |
|
Antibiotic
Combinations for Treatment of S. aureaus - M. Rybak (US)
|
|
|
|
| 12:30-13:30 |
|
Lunch,
Exhibits, Posters |
|
|
|
| 13:30-16:00 |
|
Future Treatment
Options and/or New Antibiotics
Chair
Persons: J.Schentag and A.Kumar
|
| 13:30-14:00 |
|
Activated Protein C
vs. severe Gram-Positive Infections - useful? - G.Garber (CA) |
|
14:00-14:30 |
|
ICU Management of Gram
Positive Septicemia
- A
Kumar (CA) |
|
14:30-15:00 |
|
Mediators/modulators of
Pro-inflammatory response - A El Solh (US) |
| 15:00-15:30 |
|
Panel
Discussions - New and Old Pathways and Inhibitors |
|
|
|
